A Mixed-methods Acceptability Study of ProACTive to Help Burns Patients Adjust to Changes to Appearance

A Mixed-methods Acceptability Study of ProACTive, an Early Acceptance and Commitment Therapy Intervention to Help Burns Patients Adjust to Changes to Appearance

This mixed-methods acceptability study aims to investigate whether an early acceptance and commitment therapy (ACT) based intervention called ProACTive, aimed at supporting burns patients' adjustment to a changed appearance and preventing distress, is acceptable. This will be measured by descriptive data, questionnaire data and semi-structured interviews.

Preliminary data on the potential clinical effectiveness of the intervention will also be gathered. This will be measured by scores on standardised questionnaires.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Evidence suggests that appearance concerns after burn injuries start early. Appearance concerns can be chronic, create psychological distress and impact quality of life. No early psychological interventions for appearance concerns after burn injuries currently exist.

ProACTive, a novel psychological intervention (talking therapy), utilising acceptance and commitment therapy (ACT) techniques with an additional focus on developing self-compassion and social skills training, was developed. It aims to help burns patients adjust to changes to appearance and prevent distress. It involves up to five 30-minute modules and patients can select how many, and which, modules to complete. It is delivered by a psychological professional working in burns services.

The primary aim of this study is to explore whether the ProACTive intervention is acceptable to burns patients. A secondary objective is to gather preliminary data on the potential clinical effectiveness of the ProACTive intervention.

A mixed-methods single-arm acceptability study will be conducted.

ProACTive will be offered to burns patients (aged 18 years or over) meeting inclusion criteria and admitted to the burns service at Nottingham University Hospitals NHS Trust.

Fifteen participants will be recruited to complete the intervention.

The primary objective of exploring the acceptability of the ProACTive intervention will be measured by:

  • Intervention update rate (percentage of those invited to participate in the study)
  • Descriptive data about reasons for not taking up the intervention (if patients consent to participating in the study in this way)
  • Patient feedback gathered through a semi-structured exit interview as soon as possible after the intervention ends (within two weeks)
  • Patient feedback gathered using a standardised self-report questionnaire to record helpful and hindering aspects of the intervention will be completed after every session completed.
  • Descriptive data about how many, and which of, the sessions patients choose to complete and the spacing of sessions completed
  • The number of sessions completed during hospital admission and after hospital discharge, and whether these were completed face to face or virtually
  • Descriptive data about participants' preferences for receiving the post-session resources in paper or electronic format
  • The number of times participants viewed the post-session online videos containing audio-exercises
  • Descriptive data about reason for ending the intervention before all sessions have been completed

Template analysis (King, 2012), a form of thematic analysis (Braun & Clarke, 2006), will be used to analyse patterns of meaning, or themes, within the transcripts of the interviews. The Theoretical Framework of Acceptability (TFA; Sekhon et al., 2017) will also be used to develop the interview schedule and the initial coding template.

The secondary objective to gather preliminary data on the potential clinical effectiveness of the ProACTive intervention will be examined through scores on four standardised self-report measures of:

  • Appearance concerns
  • Positive and negative affect
  • Psychological flexibility
  • Self-compassion

These measures will be completed before and after the intervention. Wilcoxon tests will be used to compare pre- and post-intervention scores. These exploratory analyses will indicate the extent to which appearance concerns decrease, and psychological flexibility and self-compassion increase post-intervention compared to pre-intervention. Differences between pre- and post-intervention means will also give an indication of the likely effect size of the intervention (Cohen's d).

The outcome of the study will include knowledge about whether ProACTive is acceptable to burns patients when it is introduced during hospital admission and preliminary evidence about the effectiveness of ProACTive. These outcomes will contribute to further intervention refinement and trial development.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nottingham, United Kingdom, NG7 2UH
        • Nottingham University Hospitals Nhs Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients (18 years and over) admitted as inpatients to the burns service with an acute burn injury

Exclusion Criteria:

  • Patients already receiving psychological input from the burns clinical psychology service for appearance related concerns, over and above supportive listening
  • Patients admitted as inpatients to the burns service for reconstructive surgery, for a historical burn injury
  • Patients who are too physically unwell to participate
  • Patients deemed too psychologically unwell or in a mental health crisis by the usual clinical care team (for example, patients who sustained their burn injury due to a suicide attempt or self-harm, are currently having suicidal thoughts, or those with psychosis)
  • Patients who are not fluent in the English language in order to participate
  • Patients with a known cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ProACTive intervention
ProACTive intervention. Participants will choose how many, and which, modules to complete.
ProACTive intervention, a talking therapy utilising acceptance and commitment therapy (ACT) techniques.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Esteem Scale for Adolescents and Adults - Appearance subscale (BESAA-A)
Time Frame: As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending
A 10-item self-report questionnaire that measures appearance concerns/body esteem. Responses to each item fall on a scale between 0 and 4. The total mean score is used, falling between 0 and 4. Higher scores indicate higher appearance esteem (i.e. lower appearance concerns).
As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive and Negative Affect Schedule (PANAS-GEN)
Time Frame: As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending
A 20-item standardised measure of positive and negative affect. Responses to items are scored between 1 and 5. Ten items relate to positive affect and 10 items relate to negative affect. Scores range from 10 to 50 for both sets of items. For the total positive score, a higher score indicates more positive affect. For the total negative score, a lower score indicates less negative affect. The total score is calculated by the sum of the 10 positive items and then the 10 negative items.
As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending
Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT)
Time Frame: As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending
A 23-item self-report questionnaire that measures psychological flexibility. Responses to each item fall on a scale between 0 and 6. The total score is used, ranging from 0 to 138. Three subscale scores can also be generated. Higher scores indicate greater psychological flexibility.
As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending
Self-Compassion Scale - Short Form (SCS-SF)
Time Frame: As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending
A 12-item self-report questionnaire that measures self-compassion. Responses to items fall on a scale between 1 and 5. The total mean score is used, with values ranging between 1 and 5. Higher scores indicate higher self-compassion.
As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending
Helpful Aspects of Therapy Form (HAT)
Time Frame: As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending
A seven-item self-report questionnaire that gathers mainly qualitative data about helpful and hindering aspects of therapy sessions.
As soon as is feasible before and after the intervention. The post-intervention measure will be completed within one week of the intervention ending

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2024

Primary Completion (Actual)

March 5, 2025

Study Completion (Actual)

March 5, 2025

Study Registration Dates

First Submitted

April 17, 2024

First Submitted That Met QC Criteria

April 17, 2024

First Posted (Actual)

April 22, 2024

Study Record Updates

Last Update Posted (Actual)

June 27, 2025

Last Update Submitted That Met QC Criteria

June 23, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24CP001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Open Science Framework. Final template of themes (qualitative data).

IPD Sharing Time Frame

Acceptance of manuscript for publication.

IPD Sharing Access Criteria

The data will be made publicly available on the Open Science Framework upon acceptance of the manuscript for publication.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burns

Clinical Trials on ProACTive

Subscribe